Gapping up
In reaction to strong earnings/guidance:
- ABB +5.4%, UAL +3.9%, CSX +3.6%, ERIC +3.3%, MS +2.7%, IBKR +2.1%, PEP +2.1%, TXT +1.6%, NFLX +1.4%, ASML +1.2%, CHCO +0.8%, PNR +0.4%, ABT +0.4%
Other news:
- SFS +20.2% (to be acquired by funds managed by affiliates of Apollo Global Management)
- UXIN +15.9% (says report published by J Capital Research contains errors of facts, misleading speculations and malicious interpretations of events)
- JMIA +13.7% (continued momentum in recent IPO)
- HOLI +13.7% (to withdraw its previously announced public offering of 7.8 mln of its ordinary shares due to market conditions)
- SELB +9.6% (to present new preclinical data from its gene and cell therapy program)
- QCOM +8.8% (continued strength on AAPL / QCOM news; also upgraded to Buy from Hold at Stifel; tgt raised to $100 from $57)
- TUFN +8% (continued volatility in recent IPO name)
- TXMD +6.7% (signed a binding commitment letter for a $300 million non-dilutive secured term loan financing facility with TPG Sixth Street Partners)
- INTC +4.1% (to exit 5G smartphone modem business; to focus 5G efforts on network infrastructure)
- ERIC +3.3% (ahead of earnings tomorrow before the open)
- ADMA +3.3% (granted U.S. Patent No. 10,259,865 related to methods of treatment and prevention of S. pneumonia infection)
Analyst comments:
- ORGO +4.4% (initiated with Outperform at Oppenheimer)
- ZSAN +3.7% (initiated with a Buy at Maxim Group; tgt $8)
- CGC +3.3% (initiated with a Buy at BofA/Merrill)
- ACB +3% (initiated with a Buy at BofA/Merrill)
- DPZ +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- TSS +1.7% (upgraded to Buy from Neutral at Goldman)
- TDOC +1.1% (initiated with Overweight rating and $75 tgt at Stephens)